The potential of cannabidiol in the COVID‐19 pandemic

Identifying drugs effective in the new coronavirus disease 2019 (COVID‐19) is crucial, pending a vaccine against SARS‐CoV2. We suggest the hypothesis that cannabidiol (CBD), a non‐psychotropic phytocannabinoid, has the potential to limit the severity and progression of the disease for several reason...

Descripción completa

Detalles Bibliográficos
Autores principales: Esposito, Giuseppe, Pesce, Marcella, Seguella, Luisa, Sanseverino, Walter, Lu, Jie, Corpetti, Chiara, Sarnelli, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Themed Issue: Hypothesis Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300643/
https://www.ncbi.nlm.nih.gov/pubmed/32519753
http://dx.doi.org/10.1111/bph.15157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300643/
https://www.ncbi.nlm.nih.gov/pubmed/32519753
http://dx.doi.org/10.1111/bph.15157

Ejemplares similares